New cancer clinical trial: FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET

Published on: November 01, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share